Indigo, which raised $560 million last year, said the layoffs align with its new CEO’s goal “to direct resources to [its] four primary offerings” and “realize their value.”
The duo will commercialize the US startup’s “green chemistry” product that helps plants use fertilizer more efficiently through microbes.
The Costa Rican startup tells AFN about its experience of raising capital in its home country.
FBN’s recently unveiled Biological On-Farm R&D Network will connect developers of biological ag inputs directly with farmers to perform trials in full-scale testing environments.
Instead of just identifying helpful microbes, Boost wants to explore how microbe ecology may unlock even more benefits for farmers
With the new acquisition, RNAissance plans to ramp up production of its sprayable RNA pesticides while expanding production.
The publicly-traded company is responding to the increasing number of countries banning chemical inputs by innovating bio-based solutions.
The startup offers a molecular biology-backed line of crop inputs as well as a platform to rapidly create new seed traits without gene-editing techniques.
Syngenta Ventures’ Michael Lee tells AFN how the firm is viewing the biologics space and why WeedOut’s species-specific approach is so important.
It also announced some changes to its executive leadership with CEO Tom Laurita stepping down in what it described as a streamlined approach towards advancing commercialization.
Although it’s interested in biologics, it claims farmers still need the high rate of efficacy that chemical agriculture has to offer.
From traceability to hemp to robots, if Barnes is right, 2020 is going to be a blockbuster year across the agricultural board.
Sponsored
Sponsored post: The innovator’s dilemma: why agbioscience innovation must focus on the farmer first